Breaking News

Sundeep Pharma Promoters Regain 100% Ownership from JRS Pharma

The company is poised to accelerate its R&D initiatives, expand its product portfolio, and pursue new opportunities.

Author Image

By: Charlie Sternberg

Associate Editor

Sudeep Pharma Private Limited’s promoters have completed the acquisition of shares from their joint venture partners, JRS PHARMA, regaining 100% ownership of the company—representing a significant step in Sudeep Pharma’s ongoing growth and development, enabling the company to pursue its vision. Promoters of Sudeep Pharma, Sujit Bhayani & Family, entered into a joint venture in 2015 with JRS Pharma. Combining JRS Pharma’s expertise in excipients with Sudeep Pharma’s technologi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters